Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2010
08/19/2010US20100212040 Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
08/19/2010US20100212038 Transgenic fish with tissue-specific expression
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100212033 Novel ubiquitin lifases as therapeutic tragets
08/19/2010US20100212032 Compositions and Methods for the Efficient and Reproducible Generation of Clone Animals of All Developmental Stages and Methods of Use Thereof
08/19/2010US20100212029 Novel assays utilizing nicotinic acetylcholine receptor subunits
08/19/2010US20100210830 System for inducible expression in eukaryotic cells
08/19/2010US20100210718 Synergistic anti-oxidant treatment for lipotoxicity and other metabolically related phenomena
08/19/2010US20100210715 Biodegradable cationic polymers
08/19/2010US20100210712 Short RNA Antagonist Compounds for the Modulation of Target mRNA
08/19/2010US20100210710 THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO
08/19/2010US20100210707 Small Activating RNA Molecules and Methods of Use
08/19/2010US20100210686 Therapeutic agents useful for treating pain
08/19/2010US20100210639 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h 1,3,6,9 tetraaza-fluorenes as chk1 kinase function inhibitors
08/19/2010US20100210569 Mitochondria-targeting antioxidant therapeutics
08/19/2010US20100210566 Azapeptides as cd36 binding compounds
08/19/2010US20100210551 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210550 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210549 Novel Bacillus Thuringiensis Crystal Polypetides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210548 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210530 Extracellular matrix compositions
08/19/2010US20100210525 Combined preparation of a thiazide diuretic and a loop diuretic
08/19/2010US20100210508 Method for the Massive Culture of Cells Producing Recombinant Human Erythropoietin
08/19/2010US20100210504 Enhanced transport using membrane disruptive agents
08/19/2010US20100210039 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein
08/19/2010US20100210016 Rotation system for cell growth chamber of a cell expansion system and method of use therefor
08/19/2010US20100210015 Photochemical activation of surfaces for attaching biomaterial
08/19/2010US20100210014 Nuclear reprogramming factor and induced pluripotent stem cells
08/19/2010US20100210013 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
08/19/2010US20100210012 Purified mammalian cytokines; related reagents and methods
08/19/2010US20100209990 11 beta hydroxysteroid dehydrogenase type 1
08/19/2010US20100209969 Geraniol synthase, methods of production and uses thereof
08/19/2010US20100209963 Photo-electric device and method for high throughput activation, guidance and poration of targeted cells with high spatial resolution
08/19/2010US20100209959 Tumour-cell-fixing cells
08/19/2010US20100209955 Methods For The Delivery Of Toxins Or Enzymatically Active Portions Thereof
08/19/2010US20100209939 Bnp(1-32) epitope and antibodies directed against said epitope
08/19/2010US20100209907 Isolated mammalian monocyte cell genes; related reagents
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209902 Use of a Globin, a Globin Protomer or an Extracellular Hemoglobin for the Preservation of Organs, Tissues, Organ and Tissue Cells and Cell Cultures
08/19/2010US20100209509 Bifunctional-modified hydrogels
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209453 Circovirus sequence associated with piglet weight loss disease (pwd)
08/19/2010US20100209447 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209440 Targeted Delivery of siRNA
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209432 Monoclonal antibodies against glypican-3
08/19/2010US20100209431 Metal triangulo compound and methods of using the same
08/19/2010US20100209428 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
08/19/2010US20100209425 Blood-Brain Barrier Targeting Anti-bodies
08/19/2010US20100209422 Antibodies specific for the protofibril form of beta-amyloid protein
08/19/2010US20100209417 Antibody Treatment of Alzheimer's and Related Diseases
08/19/2010US20100209415 Chemotherapeutic methods and compositions
08/19/2010US20100209409 Method for suppressing immune system response to transplanted tissue or cells
08/19/2010US20100209405 Sericin extracted silkworm fibroin fibers
08/19/2010US20100209404 Enhanced method for producing stem-like cells from somatic cells
08/19/2010US20100209402 Agent for promoting corneal endothelial cell adhesion
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209397 Method for non-autologous cartilage regeneration
08/19/2010US20100209396 Method of Enhancing Proliferation and/or Hematopoietic Differentiation of Stem Cells
08/19/2010US20100209387 Enhanced medical implant
08/19/2010US20100209360 Method for Making a Gas from an Aqueous Fluid, Product of the Method, and Apparatus Therefor
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100205855 Host Cells and Methods for Producing 3-Methyl-2-buten-1-ol, 3-Methyl-3-buten-1-ol, and 3-Methyl-butan-1-ol
08/19/2010CA2752239A1 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/18/2010EP2219029A1 Test systems, methods and uses involving AS160 protein
08/18/2010EP2218786A1 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster), and non-human mammalian animal retaining the same
08/18/2010EP2218783A1 Novel method for the manufacturing of neurotoxins
08/18/2010EP2218778A1 Conversion of unipotent germline stem cells into pluripotent stem cells without exogenous factors
08/18/2010EP2218777A1 Cellular compositions and methods for their preparation
08/18/2010EP2218776A1 Animal protein-free media for cultivation of cells
08/18/2010EP2218775A1 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
08/18/2010EP2218772A1 Cardiomyocytes-containing device and method for manufacturing the same
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2217707A2 Genetic incorporation of 3-aminotyrosine into reductases
08/18/2010EP2217698A2 Method for optimizing blood cell transplants
08/18/2010EP2217697A1 Use of lingo-4 antagonists in the treatment of conditions involving demyelination
08/18/2010EP2058329B1 Improved secretion of neublastin
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1521827B1 Modulation of cytochrome p450 reductase activity
08/18/2010EP1036163B1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN1795266B Method for producing retinal neurocyte from neural stem cell derived from iris tissue and retinal, neurocyte produced by the process
08/18/2010CN101809162A anti-glypican-3 antibody having improved kinetics in plasma
08/18/2010CN101809161A Method of producing heterogeneous protein
08/18/2010CN101809156A Method of expanding human hepatocytes in vivo
08/18/2010CN101809153A Factor involved in latent infection with herpesvirus, and use thereof
08/18/2010CN101809152A Fluorescent protein with deep blue color
08/18/2010CN101808672A New stem cell lines, their application and culture methods
08/18/2010CN101806804A Reagent for detecting acute myocardial infarction by immunological method and test strip
08/18/2010CN101805741A Male sterility gene TCL, coded protein and promoter, plasmid and host cell
08/18/2010CN101805735A Regulation and control fragment related to arsenic response and application thereof
08/18/2010CN101805726A Heat-resistance neutral xylanase, coding gene and application thereof
08/18/2010CN101805723A Anti-glutamate dehydrogenase protein monoclonal antibody, preparation method thereof and use thereof